Arvee Laboratories (India) Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.

Results View source PDF Explain this filing

ARVEE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.3%Reaction day

₹163.45

prior close

₹172.90

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.6%+1.7% vs market

Specialty Chemicals peers, median of 85sector-0.3%+2.6% vs sector

On the reaction day the stock moved 1.7 pts more than Nifty Microcap 250 and 2.6 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

-0.5

30m

-0.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.3+0.6+1.7-0.3+2.6

Next day

+1.6-0.2+1.8-1.2+2.7

+1.4-0.4+1.8-1.4+2.8

+1.5-0.7+2.2-1.9+3.4

+1.5-2.2+3.7-2.7+4.2

-0.9-2.8+1.9-4.2+3.3

+0.2-1.4+1.6-3.6+3.7

15d

+31.5-7.0+38.6-7.7+39.3

+28.8-6.1+34.9-7.1+35.9

+3.4-9.2+12.6-10.8+14.2

+2.8-6.8+9.6-11.4+14.2

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 85Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Arvee Laboratories (India) Limited has submitted its financial results for the quarter and half-year ended September 30, 2025 (Q2 FY26) to the stock exchange. The announcement itself is a procedural disclosure confirming filing compliance and does not include the detailed numbers. Investors will need to refer to the actual results document or the company's press release for specific figures on revenue, profit, margins, and segment performance. The filing timing is in line with SEBI's quarterly disclosure requirements for listed entities.

Likely market impact

This is a routine regulatory filing with no immediate price impact. Investors should review the detailed results for actual revenue, profit, and margin trends to assess the company's quarterly performance.